SCHEMBL20839160

SCHEMBL20839160

O=c1cc(-c2ccc(F)cc2Cl)c2cc[c]cc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 5/20 0.41
▸ CA9 Q16790 5/20 0.41
▸ GRM2 Q14416 2/20 0.35
▸ KCNA3 P22001 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ CSNK2A2 P19784 1/20 0.35
▸ CSNK2B P67870 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ PDE3B Q13370 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ ALOX5 P09917 1/20 0.32
▸ TDO2 P48775 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31089799 0.81 CA12 (0.51) CA12CA9GRM2KCNA3PIM1
SCHEMBL20839408 0.77 CA12 (0.69) CA12CA9KMT2AKDM4EALDH1A1
SCHEMBL30228226 0.77 CA12 (0.69) CA12CA9KMT2AKDM4EALDH1A1
SCHEMBL30227956 0.77 CA12 (0.48) CA12CA9GRM2KCNA3PIM1
SCHEMBL30228177 0.77 KDM4E (0.49) CA12CA9GRM2KCNA3PIM1
SCHEMBL30228096 0.77 CA12 (0.48) CA12CA9KCNA3MEN1KMT2A
SCHEMBL27943249 0.77 CA12 (0.43) CA12CA9KCNA3ALOX5MEN1
SCHEMBL30228063 0.75 CA12 (0.46) CA12CA9GRM2KCNA3PIM1
SCHEMBL30228316 0.74 SLC18A1 (0.47) CA12CA9KCNA3MEN1KMT2A
SCHEMBL30227943 0.74 CA12 (0.45) CA12CA9GRM2KCNA3PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3684762-A1 COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER Lead Discovery Center GmbH (DE) 2020-07-29 — — EP disclosed
WO-2019057821-A1 COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER LEAD DISCOVERY CENTER GMBH (DE) 2019-03-28 — — WO disclosed
Send feedback